Keleştimur, H. Et Al. 2018. Agomelatine prevents streptozotocin-induced diabetes and ameliorates diabetic encephalopathy in mice. Europhysiology2018 , (Londra, United Kingdom), 241.

Keleştimur, H., Özcan, M., Bulmuş, Ö., Ülker, N., Serhatlioğlu, İ., Kaçar, E., ... AYAR, A.(2018). Agomelatine prevents streptozotocin-induced diabetes and ameliorates diabetic encephalopathy in mice . Europhysiology2018 (pp.241). Londra, United Kingdom

Keleştimur, Haluk Et Al. "Agomelatine prevents streptozotocin-induced diabetes and ameliorates diabetic encephalopathy in mice," Europhysiology2018, Londra, United Kingdom, 2018

Keleştimur, Haluk Et Al. "Agomelatine prevents streptozotocin-induced diabetes and ameliorates diabetic encephalopathy in mice." Europhysiology2018 , Londra, United Kingdom, pp.241, 2018

Keleştimur, H. Et Al. (2018) . "Agomelatine prevents streptozotocin-induced diabetes and ameliorates diabetic encephalopathy in mice." Europhysiology2018 , Londra, United Kingdom, p.241.

@conferencepaper{conferencepaper, author={Haluk Keleştimur Et Al. }, title={Agomelatine prevents streptozotocin-induced diabetes and ameliorates diabetic encephalopathy in mice}, congress name={Europhysiology2018}, city={Londra}, country={United Kingdom}, year={2018}, pages={241} }